(Q35917193)

11 August 2017

1 reference

title

Pneumolysin in the immunopathogenesis and treatment of pneumococcal disease (English)

1 reference

11 August 2017

Riana Cockeran

1

1 reference

11 August 2017

Ronald Anderson

series ordinal

2

1 reference

11 August 2017

Charles Feldman

series ordinal

3

1 reference

11 August 2017

publication date

1 August 2003

1 reference

Expert Review of Anti-infective Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

1

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

231-239

1 reference

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Essential role of domain 4 of pneumolysin from Streptococcus pneumoniae in cytolytic activity as determined by truncated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Pneumococcal virulence factors: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Structural analysis of the protein/lipid complexes associated with pore formation by the bacterial toxin pneumolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Proinflammatory interactions of pneumolysin with human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Contribution of pneumolysin and autolysin to the pathogenesis of experimental pneumococcal endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Decreased virulence of a pneumolysin-deficient strain of Streptococcus pneumoniae in murine meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Protection against bacteremic pneumococcal infection by antibody to pneumolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Dexamethasone in adults with bacterial meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Immunomodulation by macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Accelerated resequestration of cytosolic calcium and suppression of the pro-inflammatory activities of human neutrophils by CGS 21680 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Cellular apoptosis and organ injury in sepsis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Apoptosis and caspases in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.1.2.231

21 January 2018

Identifiers

DOI

10.1586/14787210.1.2.231

1 reference

11 August 2017

1 reference